Cargando…
Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy
While immunotherapies have revolutionized treatment for other cancers, glioblastoma multiforme (GBM) patients have not shown similar positive responses. The limited response to immunotherapies is partly due to the unique challenges associated with the GBM tumor microenvironment (TME), which promotes...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603567/ https://www.ncbi.nlm.nih.gov/pubmed/37901257 http://dx.doi.org/10.1039/d3ra01153d |